It was possible to create a new generation drug for the treatment of autoimmune diseases. There are no analogues to it in the world. Clinical trials will begin in the near future, but preliminary studies have already shown the high effectiveness of the drug and its safety. The peculiarity of our drug is that it acts only on diseased cells, without suppressing the general immune background.